Introduction {#s1}
============

*Acinetobacter* species are mostly free-living saprophytes found ubiquitously in nature and are considered part of the normal flora of the human skin (Vallenet et al., [@B25]). Among *Acinetobacter* species, *A. baumannii* is the most important member often associated with hospital-acquired infections worldwide and is responsible for opportunistic infections of the skin, bloodstream, urinary tract, and other soft tissues. Although most *A. baumannii* infections occur in critically ill patients in the intensive care unit setting, the frequency of community-acquired *A. baumannii* infections has been increasing gradually. Furthermore, *A. baumannii* has been showed to rapidly develop resistance to antimicrobials (Lee et al., [@B15]).

*Acinetobacter* species are hosted by several insect species (Dillon and Dillon, [@B6]) but the occurrence of *A. baumannii* in hematophagous groups is poorly documented. It has been isolated from *Aedes albopictus* in Madagascar (Minard et al., [@B19]), moth fly species *Clogmia albipunctata* with colonization rates of 0--17.5% in several German hospitals (Faulde and Spiesberger, [@B8]) or Brazilian phlebotomine sand flies *Lutzomyia longipalpis* (Gouveia et al., [@B9]). *A. baumannii* DNA have also been detected in human body lice, suggesting that lice can possibly transmit this pathogen. It was first isolated from body lice collected from homeless people in Marseille (La-Scola et al., [@B13]). A 21% prevalence of *A. baumannii* DNA was then found in a large collection of 622 body lice collected in France, Burundi, Rwanda, Peru, Algeria, Portugal, and the Netherlands (La-Scola and Raoult, [@B14]). It has also been isolated at high rates from body lice collected from Ethiopian subjects (Kempf et al., [@B12]) and finally from body lice collected from Algerian homeless people (Louni et al., [@B16]). *A. baumannii* DNA was detected in head lice from French children (Bouvresse et al., [@B4]), and from infested people in Thailand (Sunantaraporn et al., [@B24]), Republic of Congo, Niger, and Algeria (Amanzougaghene et al., [@B2]; Mana et al., [@B18]; Louni et al., [@B17]). Phenotypic and genotypic features of *A. baumannii* isolates from body lice differ significantly from *A. baumannii* clinical isolate from humans (Vallenet et al., [@B25]). Experimental infection of lice by feeding on infected rabbits demonstrated that they were able to acquire and maintain a persistent life-long infection with *A. baumannii*. Moreover, infected body lice excreted living *A. baumannii* within their feces and did not transmit their infection to their nurse host during feeding or transovarially (Houhamdi and Raoult, [@B11]).

Natural lice infection may result from the ingestion of infective blood meals from patients with ongoing bacteremia, or from the penetration of colonized human skin by lice mouth parts during feeding. To challenge this hypothesis, we conducted an epidemiological study among Marseille homeless individuals addressing the presence of *A. baumannii* DNA on human skin and blood and in body lice collected from the same individuals.

Methods {#s2}
=======

Cohorts
-------

In our one-shot studies, all adult homeless people residing in two Marseille emergency shelters were enrolled on a voluntary basis in winter in 2013 and 2014. The participants completed a specially designed questionnaire providing information on demographics, chronic medical conditions, substance abuse, cutaneous symptoms (pruritus, scratch lesions), and were physically examined by the medical doctor.

Samples
-------

Body lice were removed from the clothes and body of the infested participants, transferred to sterile plastic tubes and were subsequently processed for molecular analysis ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). Four skin (hair, neck, armpits, and pelvic belt) swabs and one blood sample (collected in EDTA tube) were obtained from each participant. In the laboratory, each louse was washed with 200 μl of sterile water and then decontaminated by immersion in 70% ethanol and 0.2% eosin for 5 min as previously described (La-Scola et al., [@B13]). After being crushed, lice were placed in tubes containing 180 μl tampon G2 and 20 μl proteinase K (QIAGEN, Hilden, Germany) and the samples were incubated at 56°C overnight. The skin swabs were resuspended in 1 ml of HBSS (Hank\'s balanced salt solution). The blood samples were incubated in the BACTEC 9240 system (Reisner and Woods, [@B21]) and were considered negative for *A. baumannii* if no bacterial growth was detected after 5 days.

DNA Extraction
--------------

The automated DNA extraction was performed on 190 μl collected samples from skin swabs, blood, lice-washing liquid, crushed lice using a BioRobot®EZ1 Advanced XL instrument (QIAGEN, Hilden, Germany) and DNeasy® Blood & Tissue according to the manufacturer\'s instructions. The quality of all DNA extracts was assessed by real-time PCR (qPCR) targeting internal control TISS phage that was added to each extraction (Sow et al., [@B23]).

Real-Time PCR
-------------

The ready-to-use reaction mix Light-Cycler® 480 Probes Master (Roche Diagnostics, Meylan, France) was used for PCR assay performed in the C1000 Touch™ Thermal Cycle (Bio-Rad, USA) according to the manufacturer\'s recommendations. Positive control (Plasmid DNA) and negative control template (PCR mix + sterile H~2~O or *A. spp*. other than *A. baumannii*) were incorporated in each experimental run. For homeless samples, results were considered positive accepted when the cycle threshold value of real-time PCR was ≤35.

Specific Identification of *Acinetobacter baumannii*
----------------------------------------------------

We designed a novel qPCR system by choosing *A. baumannii*-specific gene encoding for Type VI secretion system *OmpA/MotB* (accession number [CP019034.1](CP019034.1), GenBank) because of its presence in all sequenced genomes of *A. baumannii* available in the public domain (Hassan et al., [@B10]). Our detailed experimental procedures are described in supplementary material ([Technical Appendix](#SM1){ref-type="supplementary-material"}).

Statistical Analysis
--------------------

Collected data were statistically treated using SPSS 23.0 software. Missing data and unidentified samples were not analyzed. Statistical differences in baseline characteristics were evaluated by Pearson\'s chi-square or Fisher\'s exact tests as categorical variables. A two-tailed *p*-value \< 0.05 was considered as statistically significant. We performed a binomial logistic regression with *A. baumannii* DNA carriage on the skin as a dependent variable. Univariate analysis based on only variables with a prevalence ≥ 5.0% by descriptive analysis was used to examine associations between multiple factors (demographic, chronic medical condition) and cutaneous clinical presentations toward prevalence of *A. baumannii* DNA skin-carriage. The initial model, therefore, included variables presenting a *p*-value \< 0.2. The step-wise regression procedure and likelihood-ratio tests were applied to determine the final model.

Results {#s3}
=======

Participant Characteristics ([Table 1](#T1){ref-type="table"})
--------------------------------------------------------------

At enrolment, the population of 332 homeless people (shelter A \[56%\] and B \[44%\]) was mainly men with a mean age of 41 ± 14.1 years old (range, 19--84 years). About 16% were French while the rest (84%) were migrants, originating mostly from African countries and having settled in France \~9 years before the survey was conducted. Overall, the average duration of homelessness was about 3 years and chronic homelessness, defined as an episode of homelessness ≥1 year, accounted for 42.8% of cases. A 22.3% prevalence of pruritus was recorded, in line with 17.5% individuals presenting with scratch lesions. Body lice were observed on 24 participants (7.4%); however, only 15 among them allowed our team to collect their lice.

###### 

Univariate analysis and multivariate analysis with *Acinetobacter baumannii* DNA-carriage on the skin as a dependent variable.

  **Characteristics**                                              **Total *N***      ***Acinetobacter baumannii* on the skin *N* (%)**   **No *Acinetobacter baumannii* on the skin *N* (%)**   **Univariate analysis Odds ratio (95%CI), *p*-value**   **Multivariate analysis Odds ratio (95%CI), *p*-value**
  ---------------------------------------------------------------- ------------------ --------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------- ---------------------------------------------------------
  **Total**                                                        **332**            **33 (10.8)**                                       **272 (89.2)**                                                                                                 
  **YEAR OF STUDY**                                                                                                                                                                                                                                      
  2014                                                             144 (43.4)         15 (12.8)                                           102 (87.2)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  2013                                                             188 (56.6)         18 (9.6)                                            170 (90.4)                                             0.72 (0.35--.49), *p* = 0.38                            
  **SHELTER**                                                                                                                                                                                                                                            
  B                                                                146 (44.0)         18(12.9)                                            122 (87.1)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  A                                                                186 (56.0)         15 (9.1)                                            150 (90.9)                                             0.68 (0.33--1.40), *p* = 0.29                           
  **GENRE**                                                                                                                                                                                                                                              
  Female                                                           11 (3.3)           0 (0)                                               5 (100)                                                N/A                                                     
  Male                                                             321 (96.7)         33 (11.0)                                           267 (89.0)                                                                                                     
  **AGE**                                                                                                                                                                                                                                                
  Mean age (SD) (years)                                            41 ± 14.1          N/A                                                                                                                                                                
  Age range (years)                                                19--84             N/A                                                                                                                                                                
  ≤40 years of age[^c^](#TN3){ref-type="table-fn"}                 170 (52.1)         15 (9.7)                                            139 (90.3)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  \>40 years of age                                                156 (47.9)         18 (12.2)                                           129 (87.8)                                             1.29 (0.63--2.67), *p* = 0.5                            
  Unknown[^b^](#TN2){ref-type="table-fn"}                          6 (--)                                                                                                                                                                                
  **BIRTHPLACE**                                                                                                                                                                                                                                         
  France (mainland)                                                52 (15.9)          9 (20.5)                                            35 (79.5)                                              REF[^a^](#TN1){ref-type="table-fn"}                     
  **Migrants**                                                     **275 (84.1)**     **24 (9.3)**                                        **234 (90.7)**                                         **0.40 (0.17--0.93)**, ***p*** **= 0.03**               **--**
  Africa                                                           214 (62.1)         18 (8.9)                                            185 (91.1)                                                                                                     
  Europe                                                           36 (11.0)          2 (5.8)                                             32 (94.2)                                                                                                      
  Asia                                                             16 (5.0)           2 (14.3)                                            12 (85.7)                                                                                                      
  Other                                                            9(2.8)             2(28.6)                                             5(71.4)                                                                                                        
  Unknown[^b^](#TN2){ref-type="table-fn"}                          5 (--)                                                                                                                                                                                
  Mean duration of residence in France for migrants (SD) (years)   8.9 (0--24.4)                                                                                                                                                                         
  Range of duration of residence in France for migrants (years)    0--66                                                                                                                                                                                 
  ≤1.5 years[^c^](#TN3){ref-type="table-fn"}                       134 (50)           6 (4.9)                                             117 (95.1)                                             N/A                                                     
  \>1.5 years                                                      134 (50)           14 (10.9)                                           114 (89.1)                                                                                                     
  Unknown[^b^](#TN2){ref-type="table-fn"}                          12 (--)                                                                                                                                                                               
  No visits to country of origin since immigration                 191 (71.8)         15 (8.4)                                            164 (91.6)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  Visit to country of origin since immigration                     75 (28.2)          8 (11.8)                                            60 (88.2)                                              1.45 (0.59--3.61), *p* = 0.41                           
  Unknown[^b^](#TN2){ref-type="table-fn"}                          14 (--)                                                                                                                                                                               
  Mean duration of homelessness (SD), min, max (years)             2.8 (0--7.0)                                                                                                                                                                          
  Range of duration of homelessness                                1 month−48 years                                                                                                                                                                      
  \<1 year[^c^](#TN3){ref-type="table-fn"}                         172 (51.8)         14 (8.9)                                            143 (91.1)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  ≥1 year                                                          142 (42.8)         17(12.9)                                            115 (87.1)                                             1.6 (0.8--3.42), *p* = 0.21                             
  Unknown[^b^](#TN2){ref-type="table-fn"}                          18 (--)                                                                                                                                                                               
  **ALCOHOL CONSUMPTION**                                                                                                                                                                                                                                
  Rare or never                                                    274 (85.1)         28 (11.2)                                           233 (88.8)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  Frequent                                                         48 (14.9)          5 (10.9)                                            41 (89.1)                                              0.97 (0.35--2.66), *p* = 0.96                           
  Unknown[^b^](#TN2){ref-type="table-fn"}                          10 (--)                                                                                                                                                                               
  **SMOKING CIGARETTES**                                                                                                                                                                                                                                 
  Never                                                            123 (38.1)         13 (11.8)                                           97 (88.2)                                              REF[^a^](#TN1){ref-type="table-fn"}                     
  Yes                                                              200 (61.9)         20 (10.6)                                           168 (89.4)                                             0.89 (0.42--1.87), *p* = 0.75                           
  Unknown[^b^](#TN2){ref-type="table-fn"}                          9 (--)                                                                                                                                                                                
  Cannabis                                                         72 (22.3)          9 (13.4)                                            58 (86.8)                                              1.34 (0.59--3.04), *p* = 0.49                           
  Intravenous drug use                                             3 (0.9)            0 (0)                                               2 (100)                                                                                                        
  Snorted drug use                                                 6 (1.9)            1 (0.2)                                             4 (80)                                                                                                         
  Drug substitutes                                                 1 (0.3)            0 (0)                                               1 (100)                                                                                                        
  **CHRONIC DISEASES**                                                                                                                                                                                                                                   
  Chronic respiratory diseases                                     41 (12.3)          5 (13.9)                                            31 (86.1)                                              1.39 (0.5--3.9), *p* = 0.53                             
  Diabetes mellitus                                                11 (3.3)           0 (0)                                               11(0)                                                                                                          
  **BMI**                                                                                                                                                                                                                                                
  Mean BMI (SD) (kg/m^2^)                                          23.6 ± 5.2                                                                                                                                                                            
  Range of BMI (kg/m^2^)                                           15.1--40.2                                                                                                                                                                            
  Normal weight                                                    190 (61.3)         2 (12.4)                                            155 (87.6)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  Underweight                                                      20 (6.5)           1 (5.3)                                             18 (94.7)                                              0.39 (0.50--3.08), *p* = 0.36                           
  Overweight                                                       84 (27.1)          8 (9.9)                                             73 (90.1)                                              0.77 (0.39--1.82), *p* = 0.55                           
  Obesity                                                          16 (5.2)           1 (7.7)                                             12 (92.3)                                              0.59 (0.07--4.74), *p* = 1.00                           
  Unknown[^b^](#TN2){ref-type="table-fn"}                          22 (--)                                                                                                                                                                               
  **CLINICAL PRESENTATIONS**                                                                                                                                                                                                                             
  Pruritus                                                         72 (22.3)          7 (10.8)                                            58 (89.2)                                              0.96 (0.39--2.32), *p* = 0.93                           
  Scratch lesions                                                  55 (17.5)          7 (14.3)                                            42 (85.7)                                              1.5 (0.62--3.76), *p* = 0.36                            
  No body lice                                                     301 (92.6)         27 (9.8)                                            249 (90.2)                                             REF[^a^](#TN1){ref-type="table-fn"}                     
  **Body lice infestation**                                        **24 (7.4)**       **6 (25)**                                          **18 (75)**                                            **3.07 (1.13--8.4)**, ***p*** **= 0.022**               **3.07 (1.13--8.4)**, ***p*** **= 0.029**
  Unknown[^b^](#TN2){ref-type="table-fn"}                          7 (--)                                                                                                                                                                                

*SD, standard deviation; BMI, Body mass index; N/A, not applicable*.

*REF: Reference category*.

*Unknown: missing data or unidentified samples*.

*Median of the variable is used for analysis. Bold lines indicate the variables recruited in the initial multivariate model*.

*Acinetobacter baumannii* DNA on Human Skin ([Table 2](#T2){ref-type="table"})
------------------------------------------------------------------------------

A total of 1,266 skin swabs were obtained from 332 participants and of these, 33 individuals (of 305, \[10.8%\]) had *A. baumannii* DNA on at least 1 swab. We found that 9/319 (2.8%) hair swabs, 16/319 (5.0%) neck swabs, 6/317 (1.9%) armpit swabs, and 12/311 (3.9%) pelvic belt swabs were positive for *A. baumannii* DNA. There was no statically significant difference in the prevalence of *A. baumannii* DNA according to sampling site (*p* = 0.2).

###### 

Prevalence of *Acinetobacter baumannii* DNA-carriage of various body sites and body lice.

                                            ***Acinetobacter baumannii N* (%)**
  ----------------------------------------- -------------------------------------
  **BODY LICE**                             
  Crushed lice (*N* = 219 samples)          59 (26.9)
  Lice-washing liquid (*N* = 219 samples)   40 (18.3)
  **HUMAN SKIN**                            
  Total (*N* = 1,266 samples)               43 (3.4)
  Hair (*N* = 319 samples)                  9 (2.8)
  Neck (*N* = 319 samples)                  16 (5.0)
  Arm pits (*N* = 317 samples)              6 (1.9)
  Pelvic belt (*N* = 311 samples)           12 (3.9)

Factor Associated With *Acinetobacter baumannii* DNA Skin*-*Carriage: Multivariate Model ([Table 1](#T1){ref-type="table"})
---------------------------------------------------------------------------------------------------------------------------

The prevalence of *A. baumannii* DNA skin-carriage was lower in migrants, compared to French individuals, but was significantly higher in those infested by lice compared to others in univariate. In the multivariate analysis, only individuals infested by lice OR = 3.07 (1.13--8.4), *p* = 0.029 remained associated with an increased prevalence of *A. baumannii* DNA skin-carriage.

*Acinetobacter baumannii* DNA in Lice
-------------------------------------

We collected 1,780 lice from 15 participants. The most infested individual had 560 lice on his clothes ([Supplementary Table 4](#SM1){ref-type="supplementary-material"}). Of the 219 lice analyzed, 59 (23.9%) were positive for *A. baumannii* DNA in the crushed lice, 40 (18.3%) were positive in the lice-washing liquid ([Table 2](#T2){ref-type="table"}) and 38 (17.4%) were also positive in both crushed lice and the same lice-washing liquid. Overall, among 15 individuals whose lice were tested, 9 (60%) had at least one louse positive for *A. baumannii* DNA, 4 (26.7%) had *A. baumannii* DNA in both lice and skin samples.

*Acinetobacter baumannii* in Blood
----------------------------------

All bacterial qPCRs and cultures performed on the 298 homeless blood samples were negative.

Discussion {#s4}
==========

*Acinetobacter* has gained increasing attention in recent decades due to its ability to develop resistance on a large scale to almost all major classes of antibiotics and its capacity to survive for a long period in the environment (Peleg et al., [@B20]). While routine clinical diagnostic laboratories often have difficulties in differentiating *A. baumannii* from other *Acinetobacter spp*. (from the same genetic group but less implicated as human pathogens), herein, we established a specific real-time PCR for *A. baumannii* designed from the virulence gene encoding for Type VI secretion system *OmpA/MotB*, which showed 100% conservation pattern among all strains of *A. baumannii*.

A 10.8% prevalence of *A. baumannii* DNA skin*-*carriage was detected in our cohorts and no significant difference in *A. baumannii* DNA prevalence was observed between body sites. In previous studies, the prevalence of bacterium has been reported to be rare on the surface of the skin, about 3% in different human populations (Seifert et al., [@B22]; Aucken et al., [@B3]). Nevertheless, *A. baumannii* hand-carriage rates up to 23% were reported in healthcare workers (Almasaudi, [@B1]). The *A. baumannii* strains that cause nosocomial infections are common and highly resistant to antimicrobials (Peleg et al., [@B20]). Conversely, *A. baumannii* causing community-acquired infections are rare and highly susceptible to antimicrobial treatment (Farrugia et al., [@B7]).

*A. baumannii* DNA was present in 26.9% of lice, and the positive association between the presence of body lice and *A. baumannii* skin-carriage was highly significant in this work. An experimental study conducted in 2004 showed that lice that ingest the blood of infected rabbits become infected with *A. baumannii* but do not transmit the bacterium to healthy rabbits or to their offspring; however, they excreted the living bacteria in their feces (Houhamdi and Raoult, [@B11]). Our preliminary results suggest that lice ingest *A. baumannii* while penetrating the colonized skin. Then, as soon as lice excrete viable *A. baumannii* through lice feces that are deposed directly on the skin, the transmission may occur when the subjects scratch their skin.

Lice can move from one subject to another and, as a result, epidemic transmissions of *A. baumannii* strains may occur. The bacterial transmission by lice via the ingestion of *A. baumannii* from blood could not be documented here because no subject had *A. baumannii* bacteremia in our study. *A. baumannii* bacteremia has only been reported in two homeless in our previous surveys, making this event very unlikely (Brouqui et al., [@B5]). Consequently, as in studies on *Bartonella quintana* endocarditis, it would be very difficult to establish a causal link between *A. baumannii* infected lice and bacteremia. Further clonal investigations are needed to better assess both antimicrobial susceptibilities of isolates and genotypic profiles to challenge our hypothesis. This would directly demonstrate if viable *A. baumannii* isolates from body-lice are identical or different from those isolated from human skin.
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